Merck to Present New Data for Sotatercept and MK-0616 at ACC.23/WCC, Demonstrating Significant Progr

RAHWAY, N.J.--(BUSINESS WIRE)--$MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of clinical data from its broad and advancing cardiovascular pipeline and portfolio at the upcoming American College of Cardiology’s 72nd Annual Scientific Session toget...

Related Keywords

United States ,Canada ,Julie Cunningham ,Peter Dannenbaum ,Damini Chokshi ,Eliav Barr ,World Heart Federation Congress ,Instagram ,Linkedin ,Twitter ,Statement Of Merck Co Inc ,Merck Co Inc ,Facebook ,Bristol Myers Squibb ,Merck Research Laboratories ,American College Of Cardiology ,Drug Administration ,Exchange Commission ,Youtube ,European Medicines Agency ,Acceleron Pharma Inc ,American College ,Annual Scientific Session ,World Heart Federation ,World Congress ,New Orleans ,Merck Research ,Great Hall ,Breakthrough Therapy Designation ,Priority Medicines ,Acceleron Pharma ,Bristol Myers ,Safety Information ,Looking Statement ,Securities Litigation Reform Act ,Annual Report ,Prescribing Information ,Boxed Warning ,Medication Guide ,